Skip to content

Prevention of Cow's Milk Allergy in Children

Use of Fermented Milk in Prevention of Cow's Milk Allergy in New Born and Infant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00792090
Enrollment
142
Registered
2008-11-17
Start date
2003-11-30
Completion date
2008-07-31
Last updated
2008-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Milk Hypersensitivity

Keywords

allergy, cow's milk, sensibilisation, fermented milk, infant formula

Brief summary

Impact of fermented milk in prevention of cow's milk allergy in new born and infants

Interventions

Formula used for non breastfed children or in complement of breastfeeding

Formula used for non breastfed children or in complement of breastfeeding

Sponsors

Optimed Medizinische Instrumente GmbH
CollaboratorINDUSTRY
Bledina
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* mother before the 5th month of pregnancy * mother agreeing to stop consumption of yogurts and fermented milks during the 3rd quarter of pregnancy * mother agreeing to receive a calcium supplementation during the 3rd quarter of pregnancy * atopic mother or father and at least another atopic member (sister or brother) * parents having given written informed consent * adhesion to eviction regimen for mother and child * parents agreeing with a regular follow-up (3 visits and monthly phone call with the dietician)

Exclusion criteria

* mother in an exclusion period from another study * parents refusing to sign the informed consent * infant in a situation which could interfere with an optimal participation to the study, or which could represent a risk for the infant, according to the investigator * known or suspected immunodeficiency in the family

Design outcomes

Primary

MeasureTime frame
Sensibilisation and cow's milk allergy4, 12 and 24 months

Secondary

MeasureTime frame
Sensitization or allergy to other allergens4, 12 and 24 months
Atopic diseases (atopic dermatitis, asthma)4, 12 and 24 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026